Sagga, Hazel .
HRN: 25-97-60 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2024
CO-AMOXICLAV 625MG (TAB)
10/01/2024
10/07/2024
ORAL
625mg
TID
S/p NSVD
Waiting Final Action